Joint Venture25 Jan 2024, 10:04 pm
Laurus Labs and Krka Form Joint Venture to Expand Presence in Indian Market
AI Summary
Laurus Labs Limited and Krka, an international generic pharmaceutical company, have formed a joint venture to produce finished products for the Indian market. The joint venture company, Krka Pharma Pvt. Ltd., will have a registered capital of Indian rupees equivalent to 50 million euros, with Krka holding 51% and Laurus 49% share. The partners have agreed to subscribe to the registered capital in stages, depending on the financing needs of the joint venture's business activities. This move is expected to strengthen the business relationship between the two companies and enhance their product portfolio and market presence.,
Key Highlights
- Laurus Labs and Krka form joint venture to expand presence in Indian market
- 51% share held by Krka and 49% by Laurus
- Registered capital of Indian rupees equivalent to 50 million euros
- Plans to enter Indian market and other markets outside the European Union